Publicacións (276) Publicacións nas que participase algún/ha investigador/a

filter_list

2025

  1. Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN)

    Schizophrenia, Vol. 11, Núm. 1

  2. Effects of Alzheimer’s disease plasma marker levels on multilayer centrality in healthy individuals

    Alzheimer's Research and Therapy , Vol. 17, Núm. 1

  3. Serum Proteomic Markers in Patients with Systemic Sclerosis in Relation to Silica Exposure

    Journal of Clinical Medicine, Vol. 14, Núm. 6

2024

  1. An Injectable Composite Co-Assembled Dehydropeptide-Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy

    Advanced Functional Materials, Vol. 34, Núm. 38

  2. Another Round: Influence of Alcohol-Related Conditions and Other Drug Use-Related Disorders in Emergency Department Frequent Use – A Single-Site Matched Case-Control Study in Spain

    European Addiction Research, Vol. 30, Núm. 5, pp. 275-287

  3. Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol

    Frontiers in Psychiatry, Vol. 15

  4. Assessment of pain relief after four botulinum toxin A injection cycles in patients with post-stroke lower limb spasticity: A prospective, observational study

    Rehabilitacion, Vol. 58, Núm. 3

  5. Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia

    Schizophrenia Research, Vol. 270, pp. 260-272

  6. Clinical Manifestations

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 20, pp. e087070

  7. Functioning in schizophrenia: Recommendations of an expert panel

    Schizophrenia Research, Vol. 270, pp. 317-322

  8. Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

    Neural Regeneration Research, Vol. 19, Núm. 8, pp. 1617-1677

  9. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

  10. Increasing prevalence of self-harm, suicidal behavior and suicidal ideation throughout a three-year period in the context of COVID-19 pandemic in Spain

    Psychiatry Research, Vol. 339

  11. Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer’s disease

    GeroScience, Vol. 46, Núm. 3, pp. 2989-3003

  12. Minimum spanning tree analysis of unimpaired individuals at risk of Alzheimer's disease

    Brain Communications, Vol. 6, Núm. 5

  13. Neurofilament light chain plasma levels in major depressive disorder: a brief research report

    Frontiers in Psychiatry, Vol. 15

  14. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. Anxiety and depression played a central role in the COVID-19 mental distress: A network analysis

    Journal of Affective Disorders, Vol. 338, pp. 384-392

  2. Cenobamate in real-life setting: final outcomes of an expanded access program

    35th International Epilepsy Congress, Dublin, IRELAND

  3. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

    Psychiatry Research, Vol. 330